Loading...
Loading...
India's omega imports from UNITED STATES total $31.0K across 76 shipments from 15 foreign suppliers. RAFF & HALL PHARMACY leads with $20.6K in import value; the top 5 suppliers together control 93.5% of this origin. Leading Indian buyers include STRIDES PHARMA SCIENCE LIMITED. This corridor reflects India's pharmaceutical import demand for omega — a diversified sourcing base with multiple active suppliers from UNITED STATES.

RAFF & HALL PHARMACY is the leading Omega supplier from UNITED STATES to India, with import value of $20.6K across 3 shipments. The top 5 suppliers — RAFF & HALL PHARMACY, BIO SB INC, SPRING BIO SOLUTION, ESPEE BIOPHARMA & FINECHEM LLC, BIOGENEX LABORATORIES., — collectively account for 93.5% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | RAFF & HALL PHARMACY | $20.6K | 3 | 66.5% |
| 2 | BIO SB INC | $4.5K | 44 | 14.4% |
| 3 | SPRING BIO SOLUTION | $1.8K | 2 | 5.7% |
| 4 | ESPEE BIOPHARMA & FINECHEM LLC | $1.4K | 1 | 4.5% |
| 5 | BIOGENEX LABORATORIES., | $725 | 9 | 2.3% |
| 6 | BIO SB | $658 | 4 | 2.1% |
| 7 | R&D SYSTEMS INC | $363 | 1 | 1.2% |
| 8 | R & D SYSTEMS, INC. | $362 | 1 | 1.2% |
| 9 | M/S. AMERICAN TYPE CULTURE COLLECT | $298 | 1 | 1.0% |
| 10 | BIOGENEX LABORATORIES. | $143 | 3 | 0.5% |
| 11 | AMNEAL PHARMACEUTICAL OF LLC | $70 | 1 | 0.2% |
| 12 | FAIRHAVEN HEALTH LLC. | $67 | 1 | 0.2% |
| 13 | FAIRHAVEN HEALTH LLC | $36 | 1 | 0.1% |
| 14 | LIFESTAR PHARMA LLC | $10 | 1 | 0.0% |
| 15 | ATCC | $2 | 3 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | STRIDES PHARMA SCIENCE LIMITED | $20.6K | 3 | 66.5% |
| 2 | SENTIER CONSULTING AND HEALTHCARE PRIVATE LIMITED | $4.5K | 39 | 14.7% |
| 3 | CRENZA PHARMACEUTICALS PRIVATE LIMITED | $1.8K | 2 | 5.7% |
| 4 | LUPIN LIMITED | $1.4K | 1 | 4.5% |
| 5 | BIOGENEX LIFE SCIENCES PRIVATE LIMITED | $849 | 11 | 2.7% |
| 6 | SENTIER CONSULTING AND HEALTH CARE PVT LTD | $483 | 6 | 1.6% |
| 7 | BI BIOTECH INDIA PRIVATE LIMITED | $363 | 1 | 1.2% |
| 8 | AGILE DIAGNOSTICS | $362 | 1 | 1.2% |
| 9 | HIMEDIA LABORATORIES PRIVATE LIMITED | $298 | 1 | 1.0% |
| 10 | BLOSSOMISE STORE | $102 | 2 | 0.3% |
| 11 | SENTIER CONSULTING AND HEALTH CARE PRIVATE LIMITED | $96 | 3 | 0.3% |
| 12 | SOFTGEL HEALTH CARE PRIVATE LIMITED | $70 | 1 | 0.2% |
| 13 | BIOGENEX LIFE SCIENCES PVT LTD. | $20 | 1 | 0.1% |
| 14 | SOFTGEL HEALTHCARE PRIVATE LIMITED | $10 | 1 | 0.0% |
| 15 | Ashoka University | $1 | 2 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Omega suppliers from UNITED STATES to India include RAFF & HALL PHARMACY, BIO SB INC, SPRING BIO SOLUTION. The leading supplier is RAFF & HALL PHARMACY with import value of $20.6K USD across 3 shipments. India imported Omega worth $31.0K USD from UNITED STATES in total across 76 shipments.
India imported Omega worth $31.0K USD from UNITED STATES across 76 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Omega sourced from UNITED STATES include STRIDES PHARMA SCIENCE LIMITED, SENTIER CONSULTING AND HEALTHCARE PRIVATE LIMITED, CRENZA PHARMACEUTICALS PRIVATE LIMITED. The largest buyer is STRIDES PHARMA SCIENCE LIMITED with $20.6K in imports across 3 shipments.
The total value of Omega imports from UNITED STATES to India is $31.0K USD, across 76 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
76 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists